E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

Lee Kyung Kim; Sun Ae Park; Kyung Jin Eoh; Tae Hwe Heo; Young Tae Kim; Hee Jung Kim

doi:10.7150/ijbs.37686

E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

Lee Kyung Kim, Sun Ae Park, Kyung Jin Eoh, Tae Hwe Heo, Young Tae Kim, Hee Jung Kim

Department of Obstetrics and Gynecology

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

The transcription factor E2F is an important modulator of the cell cycle, and the unrestricted activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. E2F8 is known to play an important role in embryonic development and cell cycle control by inhibiting E2F1. However, it is not yet known whether E2F8 is involved in the progression of cervical cancer. In this study, the functional consequences of E2F8 knockdown in vitro and in vivo were explored. To demonstrate the function of E2F8 in cell proliferation, migration and invasion, we knocked down E2F8 in cervical cancer cell lines; in vitro and in vivo experiments using this knockdown showed that E2F8 potently induced the expression of epithelial-mesenchymal transition (EMT) markers. Finally, clinical data confirmed that E2F8 was a significant predictive factor for progression-free survival, and that patients with cervical cancer who exhibited high expression of E2F8 showed high FIGO stages and frequent recurrence rates compared to patients with low E2F8 expression. In conclusion, our study suggests that E2F8 is highly correlated with the progression-free survival of cervical cancer patients.

Original language	English
Pages (from-to)	320-329
Number of pages	10
Journal	International Journal of Biological Sciences
Volume	16
Issue number	2
DOIs	https://doi.org/10.7150/ijbs.37686
Publication status	Published - 2019

Bibliographical note

Funding Information:
This research was supported by the Research Fund 2019 of the Catholic University of Korea, and BK21 PLUS project of the NRF funded by the Ministry of Education of Korea (22A20130012250) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI17C0321) and by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant no. NRF-2018R1D1A1B07049578, NRF-2018R1D1A1B0749780 and 2018R1A6A1A03025108).

Publisher Copyright:
© The author(s).

All Science Journal Classification (ASJC) codes

Ecology, Evolution, Behavior and Systematics
Applied Microbiology and Biotechnology
Molecular Biology
Developmental Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7150/ijbs.37686

Cite this

@article{4cf4275bb9f448c5b45bf773bde2b936,

title = "E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer",

abstract = "The transcription factor E2F is an important modulator of the cell cycle, and the unrestricted activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. E2F8 is known to play an important role in embryonic development and cell cycle control by inhibiting E2F1. However, it is not yet known whether E2F8 is involved in the progression of cervical cancer. In this study, the functional consequences of E2F8 knockdown in vitro and in vivo were explored. To demonstrate the function of E2F8 in cell proliferation, migration and invasion, we knocked down E2F8 in cervical cancer cell lines; in vitro and in vivo experiments using this knockdown showed that E2F8 potently induced the expression of epithelial-mesenchymal transition (EMT) markers. Finally, clinical data confirmed that E2F8 was a significant predictive factor for progression-free survival, and that patients with cervical cancer who exhibited high expression of E2F8 showed high FIGO stages and frequent recurrence rates compared to patients with low E2F8 expression. In conclusion, our study suggests that E2F8 is highly correlated with the progression-free survival of cervical cancer patients.",

author = "Kim, {Lee Kyung} and Park, {Sun Ae} and Eoh, {Kyung Jin} and Heo, {Tae Hwe} and Kim, {Young Tae} and Kim, {Hee Jung}",

note = "Funding Information: This research was supported by the Research Fund 2019 of the Catholic University of Korea, and BK21 PLUS project of the NRF funded by the Ministry of Education of Korea (22A20130012250) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI17C0321) and by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant no. NRF-2018R1D1A1B07049578, NRF-2018R1D1A1B0749780 and 2018R1A6A1A03025108). Publisher Copyright: {\textcopyright} The author(s).",

year = "2019",

doi = "10.7150/ijbs.37686",

language = "English",

volume = "16",

pages = "320--329",

journal = "International Journal of Biological Sciences",

issn = "1449-2288",

publisher = "Ivyspring International Publisher",

number = "2",

}

TY - JOUR

T1 - E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

AU - Kim, Lee Kyung

AU - Park, Sun Ae

AU - Eoh, Kyung Jin

AU - Heo, Tae Hwe

AU - Kim, Young Tae

AU - Kim, Hee Jung

N1 - Funding Information: This research was supported by the Research Fund 2019 of the Catholic University of Korea, and BK21 PLUS project of the NRF funded by the Ministry of Education of Korea (22A20130012250) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI17C0321) and by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant no. NRF-2018R1D1A1B07049578, NRF-2018R1D1A1B0749780 and 2018R1A6A1A03025108). Publisher Copyright: © The author(s).

PY - 2019

Y1 - 2019

N2 - The transcription factor E2F is an important modulator of the cell cycle, and the unrestricted activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. E2F8 is known to play an important role in embryonic development and cell cycle control by inhibiting E2F1. However, it is not yet known whether E2F8 is involved in the progression of cervical cancer. In this study, the functional consequences of E2F8 knockdown in vitro and in vivo were explored. To demonstrate the function of E2F8 in cell proliferation, migration and invasion, we knocked down E2F8 in cervical cancer cell lines; in vitro and in vivo experiments using this knockdown showed that E2F8 potently induced the expression of epithelial-mesenchymal transition (EMT) markers. Finally, clinical data confirmed that E2F8 was a significant predictive factor for progression-free survival, and that patients with cervical cancer who exhibited high expression of E2F8 showed high FIGO stages and frequent recurrence rates compared to patients with low E2F8 expression. In conclusion, our study suggests that E2F8 is highly correlated with the progression-free survival of cervical cancer patients.

AB - The transcription factor E2F is an important modulator of the cell cycle, and the unrestricted activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. E2F8 is known to play an important role in embryonic development and cell cycle control by inhibiting E2F1. However, it is not yet known whether E2F8 is involved in the progression of cervical cancer. In this study, the functional consequences of E2F8 knockdown in vitro and in vivo were explored. To demonstrate the function of E2F8 in cell proliferation, migration and invasion, we knocked down E2F8 in cervical cancer cell lines; in vitro and in vivo experiments using this knockdown showed that E2F8 potently induced the expression of epithelial-mesenchymal transition (EMT) markers. Finally, clinical data confirmed that E2F8 was a significant predictive factor for progression-free survival, and that patients with cervical cancer who exhibited high expression of E2F8 showed high FIGO stages and frequent recurrence rates compared to patients with low E2F8 expression. In conclusion, our study suggests that E2F8 is highly correlated with the progression-free survival of cervical cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=85077765847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077765847&partnerID=8YFLogxK

U2 - 10.7150/ijbs.37686

DO - 10.7150/ijbs.37686

M3 - Article

C2 - 31929759

AN - SCOPUS:85077765847

SN - 1449-2288

VL - 16

SP - 320

EP - 329

JO - International Journal of Biological Sciences

JF - International Journal of Biological Sciences

IS - 2

ER -

E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this